Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 368.24M P/E - EPS this Y 0.50% Ern Qtrly Grth -
Income -41.2M Forward P/E -8.12 EPS next Y 20.20% 50D Avg Chg 19.00%
Sales 39.3M PEG - EPS past 5Y - 200D Avg Chg 35.00%
Dividend N/A Price/Book 4.10 EPS next 5Y - 52W High Chg -11.00%
Recommedations 1.80 Quick Ratio 12.48 Shares Outstanding 21.60M 52W Low Chg 171.00%
Insider Own 9.56% ROA -22.43% Shares Float 11.28M Beta 1.23
Inst Own 75.25% ROE -44.51% Shares Shorted/Prior 786.47K/781.33K Price 17.78
Gross Margin 84.08% Profit Margin -104.85% Avg. Volume 165,445 Target Price 32.50
Oper. Margin -85.46% Earnings Date Jul 23 Volume 78,251 Change -3.74%
About CVRx, Inc.

CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The company offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure with reduced ejection fraction or systolic heart failure. It sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, and internationally. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.

CVRx, Inc. News
04/19/24 CVRx's (CVRX) Latest Data Favors Barostim's Long-Term Benefits
04/16/24 CVRx to Report First Quarter 2024 Financial and Operating Results and Host Conference Call on April 30th, 2024
04/15/24 CVRx announces availability of additional data supporting long-term benefits of Barostim
01/31/24 CVRx Full Year 2023 Earnings: EPS Beats Expectations
01/31/24 CVRx Announces Appointment of Kevin Hykes as President and Chief Executive Officer
01/27/24 CVRx, Inc. (NASDAQ:CVRX) Q4 2023 Earnings Call Transcript
01/26/24 Q4 2023 CVRx Inc Earnings Call
01/25/24 CVRx (CVRX) Reports Q4 Loss, Tops Revenue Estimates
01/25/24 CVRx Inc (CVRX) Reports Substantial Revenue Growth in 2023
01/25/24 CVRx Reports Fourth Quarter and Full Year 2023 Financial and Operating Results
01/22/24 CVRx (CVRX) Upgraded to Strong Buy: What Does It Mean for the Stock?
01/17/24 Private equity firms account for 44% of CVRx, Inc.'s (NASDAQ:CVRX) ownership, while institutions account for 40%
01/11/24 CVRx to Report Fourth Quarter 2023 Financial and Operating Results and Host Conference Call on January 25th, 2024
01/11/24 What Makes CVRx (CVRX) a Good Fit for 'Trend Investing'
01/08/24 CVRx Reports Preliminary Fourth Quarter and Fiscal Year 2023 Financial Results and Announces Nadim Yared Retirement Plans
12/27/23 CVRx to Present at the 42nd Annual J.P. Morgan Healthcare Conference
12/27/23 CVRx (CVRX) Moves 24.2% Higher: Will This Strength Last?
12/26/23 CVRx receives FDA approval for expanded labeling of Barostim
12/18/23 CVRx (CVRX) Is Up 10.17% in One Week: What You Should Know
12/08/23 CVRx (CVRX) is on the Move, Here's Why the Trend Could be Sustainable
CVRX Chatroom

User Image TJmaximus Posted - 1 day ago

$CVRX oh well, the rent was cheap.

User Image commoncentsinvestor Posted - 1 day ago

$CVRX Conversation CVRx | Barostim @CVRx_Inc We're happy to support the Scripps Clinical Advances in Heart Failure, Arrhythmias, and Cardiogenic Shock Symposium today in San Diego. Visit us between sessions to learn how #Barostim can improve quality of life for patients with #heartfailure. https://twitter.com/CVRx_Inc/status/1783926754324738149/photo/1

User Image TJmaximus Posted - 1 day ago

$CVRX DUKE is on board https://x.com/cvrx_inc/status/1783906559837503818?s=46&t=895_nf_tnQeu2vGeIioosw

User Image TJmaximus Posted - 2 days ago

$CVRX gap filled...spec position added.

User Image MichaelScottt Posted - 3 days ago

$CVRX nothing happening here. Guess I'll hold off on buying still.

User Image TJmaximus Posted - 4 days ago

$CVRX Donald needs to start asking himself where he went wrong on this? Down 50% in 3 months while he has been pumping it…

User Image mistermannan Posted - 4 days ago

$CVRX what a sh*tshow these last 3 months have been.

User Image futurerobo34 Posted - 4 days ago

$CVRX buy at $12.

User Image TJmaximus Posted - 5 days ago

$RCEL $CVRX these are two pump and dump specials from @commoncentsinvestor

User Image 1111tu Posted - 5 days ago

$CVRX IMO, shorts started covering today, it’s probably close enough to the gap. Short interest is in top quartile.

User Image commoncentsinvestor Posted - 5 days ago

@BeefStewart Here's a message I posted in early April about implant centers and future prospects: $CVRX 2023 began with 106 Active Implant Centers. 2023 Revenues were $39M. That represents $368,000 per Center. 2024 begins with 178 Active Implant Centers. With the same average pr Center the 2024 Revenues would come to $65M. However, as has been stated by CVRX in past earnings calls, the longer an implant center is online, the more thay do. So it would not be surprising that revenues come in even higher." Nothing has changed since then except they have added more implant centers, more territories, have had more favorable publicity about Barostim, and more seminars promoting it with physicians. With a Market Cap of only around $370M, a double in share price or more by the end of the year is very likely.

User Image MichaelScottt Posted - 6 days ago

$CVRX Wow haven't been here in a while. What's been going on? @commoncentsinvestor

User Image TJmaximus Posted - 1 week ago

$CVRX something is broken

User Image TJmaximus Posted - 1 week ago

$CVRX

User Image newfguy Posted - 1 week ago

$CVRX SLN

User Image TJmaximus Posted - 1 week ago

$CVRX looking forward to the vision from the new CEO on growing revenue, resource allocation.

User Image commoncentsinvestor Posted - 1 week ago

$CVRX 2022 1st Q earnings report was on April 25th. 2023 1st Q earnings report was on April 27th. So April 30th is pretty much in line with previous reporting dates.

User Image ThickStripe Posted - 1 week ago

$CVRX later than normal earnings date...

User Image MichaelScottt Posted - 1 week ago

$CVRX if it can hold off just a bit longer until my funds clear. I'm loving it down at this level.

User Image jlsnet22 Posted - 1 week ago

$CVRX As of the close today, SP is resting on long term ascending trendline going back 2 years .

User Image commoncentsinvestor Posted - 1 week ago

$CVRX We're honored to support Drs. Jeremy London and Daniel Cobb and the team @chooseSJC on their first #Barostim implant. Thanks for providing a novel therapy option for your #heartfailure patients. #epeeps https://twitter.com/CVRx_Inc/status/1780603195678740522

User Image TJmaximus Posted - 1 week ago

$CVRX https://x.com/CVRx_Inc/status/1780603195678740522f

User Image TJmaximus Posted - 1 week ago

$CVRX I am anticipating the new CEO to use insurance denials as an excuse for a light q1.

User Image TJmaximus Posted - 1 week ago

$CVRX The local burrito shop makes a better a burrito than Chipotle, Chipotle is the better investment.

User Image Stock_Titan Posted - 1 week ago

$CVRX CVRx to Report First Quarter 2024 Financial and Operating Results and Host Conference Call on April 30th, 2024 https://www.stocktitan.net/news/CVRX/cv-rx-to-report-first-quarter-2024-financial-and-operating-results-08kgdb8jfd99.html

User Image TriGuy8542 Posted - 1 week ago

$CVRX Skip stopped skipping, before skipping again. Skippety doo dah https://www.linkedin.com/posts/cvrx_barostim-heartfailure-activity-7186083850068877313-gsnh?utm_source=share&utm_medium=member_ios

User Image TJmaximus Posted - 1 week ago

$CVRX 14 gap looms, been saying that since price at 26.

User Image TJmaximus Posted - 1 week ago

$CVRX Company better beat $12m q1 or this falls to sub $12.

User Image jlsnet22 Posted - 1 week ago

$CVRX Approaching support near $16 per 2 year trend line.

User Image newfguy Posted - 1 week ago

$CVRX next support level 13.16

Analyst Ratings
Piper Sandler Overweight Jan 26, 24
JP Morgan Overweight Jan 26, 24
Lake Street Buy Dec 27, 23
JP Morgan Overweight Dec 20, 23
Lake Street Buy May 3, 23
Piper Sandler Overweight Feb 10, 23
Canaccord Genuity Buy Feb 7, 23
JP Morgan Overweight Jan 27, 23
Piper Sandler Overweight Nov 2, 22
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
SLATTERY JOSEPH P Director Director Dec 28 Option 1.4 1,950 2,730 22,145 01/02/24
Behbahani Ali Director Director Dec 14 Option 0.237 316 75 316 12/18/23
Galle Liz VP OF GLOBAL CLINICA.. VP OF GLOBAL CLINICAL RESEARCH Oct 16 Option 0.237 778 184 778 10/18/23
VERRASTRO PAUL CHIEF MKTG & STRAT O.. CHIEF MKTG & STRAT OFFICER Aug 03 Sell 18.5549 628 11,652 08/07/23
VERRASTRO PAUL CHIEF MKTG & STRAT O.. CHIEF MKTG & STRAT OFFICER Jul 31 Sell 17.49 1,122 19,624 2,628 08/02/23
VERRASTRO PAUL CHIEF MKTG & STRAT O.. CHIEF MKTG & STRAT OFFICER Jul 31 Option 5.14 3,750 19,275 3,750 08/02/23
Palmer Craig E. SVP, U.S. SALES SVP, U.S. SALES May 16 Option 0.237 295 70 295 05/18/23
VERRASTRO PAUL CHIEF MKTG & STRAT O.. CHIEF MKTG & STRAT OFFICER Nov 28 Sell 12.19 4,600 56,074 4,400 11/30/22
VERRASTRO PAUL CHIEF MKTG & STRAT O.. CHIEF MKTG & STRAT OFFICER Nov 28 Option 5.14 9,000 46,260 9,000 11/30/22
OASHEIM JARED CHIEF FINANCIAL OFFI.. CHIEF FINANCIAL OFFICER Jun 02 Option 0.24 9,585 2,300 9,585 06/06/22
Nielsen Kirk G. Director Director May 24 Buy 5.0498 8,070 40,752 1,711,355 05/26/22
Nielsen Kirk G. Director Director May 19 Buy 5.04 28,795 145,127 1,703,285 05/23/22
Nielsen Kirk G. Director Director Apr 28 Buy 5.97 42,088 251,265 1,612,186 05/02/22
Nielsen Kirk G. Director Director Feb 18 Buy 7.97 104,867 835,790 1,566,698 02/23/22
BRUHN-DING DEAN VP of Reg. Affairs a.. VP of Reg. Affairs and QA Feb 08 Option 0.24 35,000 8,400 54,648 02/10/22
SLATTERY JOSEPH P Director Director Jan 13 Option 0.32 11,640 3,725 20,195 01/18/22
Jain Mudit K. Director Director Nov 18 Buy 14.16 1,175 16,638 2,800 11/19/21